Agrichemicals giant rejected a second takeover offer from US rival Monsanto, which the Swiss-based rival said “continues to gloss over” potential antitrust concerns to a deal.
Monsanto overnight restated a $45 billion, or SFr449 per share, offer for Syngenta but with a $2 billion break fee attached, which would become payable to the Swiss group if the deal were scuppered by antitrust concerns.
“After three meetings over the last month with your antitrust team, we do not believe they have raised any credible theory that could be used to impede our proposed merger on the basis of competition concerns,” Monsanto said in a letter to Syngenta.
“Nevertheless, as a sign of our high degree of confidence in obtaining the necessary regulatory approvals, we are willing to commit to a reverse break-up fee of $2 billion payable if we are unable to consummate the transaction for antitrust reasons within 18 months.”
“Such a fee would be among the highest reverse break-up fees that any company has agreed to.”
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI